selected publications academic article A pharmacogenetic study of cyp2c19 in acute coronary syndrome patients of colombian origin reveals new polymorphisms potentially related to clopidogrel therapy: Estudio farmacogenético de cyp2c19 en pacientes con síndrome coronario agudo de origen colombiano revela nuevos polimorfismos potencialmente relacionados con la terapia con clopidogrel 2021-5-12
co-principal investigator on Pharmacogenetic analysis for the estimation of safety and efficacy in the response to clopidogrel in patients with acute coronary syndrome treated at MEDERI 2020-01-13 - 2021-09-30